Papers
1
Total Citations
5
H-Index
1
About
Carol Lee is a clinical researcher whose work focuses on perioperative outcomes in urologic oncology, particularly in patients undergoing robotic-assisted radical cystectomy. Her most-cited study, published in 2020, investigates the association between N-methylnaltrexone—a peripherally acting mu-opioid receptor antagonist—and clinical outcomes in this surgical population. This research addresses a critical need to mitigate opioid-related complications while preserving effective pain management in complex cancer surgeries. By exploring how targeted pharmacological interventions can reduce postoperative ileus and enhance recovery, Lee contributes to the growing field of enhanced recovery after surgery (ERAS) protocols. Although her citation count is modest, her work holds significant clinical relevance for improving patient quality of life and surgical safety. Lee’s research exemplifies the intersection of pharmacology, surgical oncology, and patient-centered care, offering insights that may shape future perioperative management strategies. Her dedication to refining outcomes for high-risk surgical patients underscores her commitment to advancing evidence-based practice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1